# Antiplatelet Therapies in Patients With Depression and Coronary Disease

> **NCT05821062** · — · UNKNOWN · sponsor: **Centro Cardiologico Monzino** · enrollment: 400 (estimated)

## Conditions studied

- Coronary Artery Disease
- Depression

## Interventions

- **OTHER:** standard Aspirin (ASA) + clopidogrel (CLP) therapy
- **OTHER:** standard Aspirin (ASA) + Ticagrelor (TCG) or Prasugrel (PSG) therapy
- **OTHER:** standard ASA therapy

## Key facts

- **NCT ID:** NCT05821062
- **Lead sponsor:** Centro Cardiologico Monzino
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-14
- **Primary completion:** 2024-02
- **Final completion:** 2024-02
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2023-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05821062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05821062, "Antiplatelet Therapies in Patients With Depression and Coronary Disease". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05821062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*